Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kohn

Showing results (241-250 of 260) with videos related to

Pageof 26
Sort By:
Contemporary Clinical Trials|March 7, 2016
HealthLinks randomized controlled trial: Design and baseline resultsPeggy A Hannon, Kristen Hammerback, Claire L Allen, et al.
Clinical Chemistry|April 1, 1978
Method-specific variations in the calibration of a new immunoglobulin standard suitable for use in nephelometric techniquesJ T Whicher, J Hunt, D E Perry, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2004
Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 4Vincent P Rocco, Patrick G Spinazze, Todd J Kohn, et al.
American Journal of Public Health|October 18, 2019
Disseminating Evidence-Based Interventions in Small, Low-Wage Worksites: A Randomized Controlled Trial in King County, Washington (2014-2017)Peggy A Hannon, Kristen Hammerback, Marlana J Kohn, et al.
Molecular and Cellular Biology|February 2, 2006
The multifunctional RNA-binding protein La is required for mouse development and for the establishment of embryonic stem cellsJung-Min Park, Matthew J Kohn, Monique W Bruinsma, et al.
Frontiers in Public Health|May 10, 2018
Readiness to Change Over Time: Change Commitment and Change Efficacy in a Workplace Health-Promotion TrialChristian D Helfrich, Marlana J Kohn, Austin Stapleton, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2003
Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 1Kumiko Takeuchi, Todd J Kohn, Nicholas A Honigschmidt, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 3Kumiko Takeuchi, Todd J Kohn, Nicholas A Honigschmidt, et al.
Nature Communications|October 14, 2015
Isotopic ordering in eggshells reflects body temperatures and suggests differing thermophysiology in two Cretaceous dinosaursRobert A Eagle, Marcus Enriquez, Gerald Grellet-Tinner, et al.
Journal of Biological Standardization|July 1, 1978
Results of the second international study on the W.H.O. alpha-foetoprotein standardL R Muenz, P Sizaret, C Bernard, et al.
Pageof 26

Showing results (241-250 of 260) with videos related to

Sort By:
Pageof 26
Contemporary Clinical Trials|March 7, 2016
HealthLinks randomized controlled trial: Design and baseline resultsPeggy A Hannon, Kristen Hammerback, Claire L Allen, et al.
Clinical Chemistry|April 1, 1978
Method-specific variations in the calibration of a new immunoglobulin standard suitable for use in nephelometric techniquesJ T Whicher, J Hunt, D E Perry, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2004
Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 4Vincent P Rocco, Patrick G Spinazze, Todd J Kohn, et al.
American Journal of Public Health|October 18, 2019
Disseminating Evidence-Based Interventions in Small, Low-Wage Worksites: A Randomized Controlled Trial in King County, Washington (2014-2017)Peggy A Hannon, Kristen Hammerback, Marlana J Kohn, et al.
Molecular and Cellular Biology|February 2, 2006
The multifunctional RNA-binding protein La is required for mouse development and for the establishment of embryonic stem cellsJung-Min Park, Matthew J Kohn, Monique W Bruinsma, et al.
Frontiers in Public Health|May 10, 2018
Readiness to Change Over Time: Change Commitment and Change Efficacy in a Workplace Health-Promotion TrialChristian D Helfrich, Marlana J Kohn, Austin Stapleton, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2003
Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 1Kumiko Takeuchi, Todd J Kohn, Nicholas A Honigschmidt, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 3Kumiko Takeuchi, Todd J Kohn, Nicholas A Honigschmidt, et al.
Nature Communications|October 14, 2015
Isotopic ordering in eggshells reflects body temperatures and suggests differing thermophysiology in two Cretaceous dinosaursRobert A Eagle, Marcus Enriquez, Gerald Grellet-Tinner, et al.
Journal of Biological Standardization|July 1, 1978
Results of the second international study on the W.H.O. alpha-foetoprotein standardL R Muenz, P Sizaret, C Bernard, et al.
Pageof 26